A new Pasteur Institute in Korea, inaugurated on April 12, will begin its research activities in September of this year. This week, it was announced that Ulf Nehrbass will be the new institute's first director, for a period of 3 years.

Nehrbass currently leads the Nuclear Cell Biology Research Unit at Pasteur in Paris. “The overall topic [of the new center] is 'from genomes to drugs,'” he told The Scientist regarding the research focus of the new institute. “This is what the Koreans wanted, and I believe that we are in a good position to deliver it.”

“We will be looking at disease models at a cellular level,” he said, “and trying to find chemical leads in order to interfere with the diseases.” The institute will concentrate its research on diagnostic tools for tuberculosis, malaria, leukemia, and stomach and liver cancer, with the deliberate aim of generating applied research.


Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?